HAART

Related by string. Haart . haart * * HAART regimen . HAART regimens . Therapy HAART . anti retroviral therapy HAART . de Haart . Haart estate . HAART initiation . haart estate . initiating HAART . HAART cocktail *

Related by context. All words. (Click for frequent words.) 80 antiretroviral therapy 73 active antiretroviral therapy 70 antiretroviral therapy ART 70 antiviral therapy 68 NNRTI 66 virologic failure 66 HAART regimens 66 potent antiretroviral therapy 66 viral load 65 cART 65 CD4 cell 65 HAART regimen 65 anti retroviral therapy 64 antiretroviral treatment 64 CD4 counts 64 lipid lowering therapy 64 PrEP 64 NRTIs 63 viral loads 63 lamivudine 63 viral suppression 63 ARV therapy 63 HCV infected 63 virological failure 63 enfuvirtide 63 antiretroviral regimen 63 peginterferon 63 HIV infected 63 NNRTIs 62 antiretroviral drugs 62 Therapy HAART 62 d4T 62 single dose nevirapine 62 virologic 62 tamoxifen therapy 61 combination antiretroviral therapy 61 protease inhibitor PI 61 antiretroviral 61 nelfinavir 61 APTIVUS r 61 imatinib 61 protease inhibitors 61 ribavirin 61 raltegravir 61 hydroxyurea 61 disease progression 61 antidepressant therapy 61 antiretrovirals 61 adalimumab 61 tenofovir 61 statin therapy 61 antiretroviral therapies 61 antiretroviral medications 60 HBV infection 60 NRTI 60 rituximab 60 antiretroviral ARV therapy 60 antiretroviral regimens 60 stavudine 60 sustained virologic response 60 sulfadoxine pyrimethamine 60 antiretroviral naive 60 mycophenolate mofetil 59 atazanavir 59 virological response 59 protease inhibitor 59 INTELENCE 59 imatinib therapy 59 NNRTI resistance 59 infliximab 59 anti retroviral therapy HAART 59 cotrimoxazole prophylaxis 59 darunavir ritonavir 59 bisphosphonate therapy 59 boosted protease inhibitor 59 d4T stavudine Zerit 59 tamoxifen 59 HBV DNA 59 Hydroxyurea 59 tipranavir 59 Highly Active Antiretroviral 59 immunosuppression 59 antihypertensive drugs 58 undetectable viral load 58 metformin 58 azathioprine 58 seroconversion 58 immunosuppressant therapy 58 coinfected patients 58 HIV RNA 58 adefovir 58 trastuzumab 58 virologic suppression 58 Antiretroviral therapy 58 HIV infection 58 entecavir 58 anastrozole 58 abacavir 58 antihypertensive therapy 58 TDF FTC 58 efavirenz 58 AZT zidovudine Retrovir 58 androgen deprivation 58 methotrexate therapy 58 LEXIVA r 58 nucleoside analogues 58 intravenous bisphosphonates 58 co trimoxazole 58 interferon 58 virologically 57 serum HBV DNA 57 nucleoside analogue 57 fosamprenavir 57 ritonavir boosted 57 pyrazinamide 57 AZT 57 decitabine 57 sustained virological response 57 HIV seroconversion 57 valproic acid 57 beta blocker therapy 57 folate supplementation 57 peg interferon 57 androgen therapy 57 CMV infection 57 GnRH agonists 57 initiating HAART 57 pyrimethamine 57 isoniazid 57 immunosuppressive agents 57 ddI 57 chloroquine 57 sunitinib 57 rhTSH 57 treatment regimens 57 lipid lowering drugs 57 darunavir 57 paricalcitol 57 coinfected 57 chemoradiotherapy 57 glatiramer acetate 57 antimicrobial prophylaxis 57 antiretroviral naïve 57 suppressive therapy 57 recurrent genital herpes 57 reperfusion therapy 57 indinavir 57 virologic response 57 peginterferon alfa 2a 57 undetectable HCV RNA 57 anti TNF 56 HIV HCV coinfected 56 ART regimens 56 DAPT 56 clozapine 56 interferon ribavirin 56 immunosuppressive therapies 56 stavudine d4T 56 statin 56 tipranavir ritonavir 56 pegylated interferon 56 DMARD 56 neoadjuvant chemotherapy 56 hydroxychloroquine 56 statins 56 antihypertensive medications 56 idarubicin 56 Imatinib 56 Antiretroviral Therapy 56 monotherapy 56 etanercept 56 ritonavir boosted protease inhibitor 56 ribavirin therapy 56 antibiotic therapy 56 statin medications 56 vicriviroc 56 HCV 56 PSADT 56 ISENTRESS 56 zidovudine AZT 56 ARV treatment 56 SIV infection 56 azacitidine 56 pharmacologic intervention 56 chronic HCV infection 56 antiretroviral medication 56 chemotherapy regimens 56 CMV disease 56 nephrotoxic drugs 56 PREZISTA r 56 insulin detemir 56 ibandronate 56 exemestane 56 postexposure prophylaxis 56 alteplase 56 prophylaxis 56 undetectable viral loads 56 herpes infections 56 glucocorticoid 56 abiraterone 56 antiepileptic drugs 56 Valcyte 56 docetaxel 56 topotecan 56 basal cell nevus syndrome 55 trimethoprim sulfamethoxazole 55 hormonal therapy 55 antiplatelet therapy 55 tolterodine 55 nevirapine Viramune 55 HSCT 55 Kaplan Meier analysis 55 therapeutic regimens 55 spironolactone 55 HBeAg negative 55 insulin glargine 55 hepatitis C virus 55 tenofovir Viread 55 protease inhibitors PIs 55 pharmacologic treatments 55 spontaneous preterm delivery 55 selenium supplementation 55 plasma viremia 55 APTIVUS 55 lamotrigine 55 rifampicin 55 abacavir lamivudine 55 superinfection 55 inhaled steroids 55 immunosuppressive regimens 55 TMP SMX 55 zoledronic acid 55 cisplatin chemotherapy 55 ribavirin RBV 55 lipoatrophy 55 HCV RNA 55 genotypic resistance 55 L dopa 55 viremia 55 ovarian stimulation 55 GnRH agonist 55 REYATAZ 55 corticosteroids 55 ritonavir boosted lopinavir 55 metastatic RCC 55 bosentan 55 antioxidant supplementation 55 COPAXONE R 55 platelet reactivity 55 rhGH 55 IFN alpha 55 CD4 55 iPrEx study 55 Natalizumab 55 LPV r 55 rFVIIa 55 cotrimoxazole 55 lopinavir 55 lamivudine 3TC 55 β blocker 55 pharmacokinetic interactions 55 trastuzumab Herceptin ® 55 pyridostigmine 55 corticosteroid therapy 54 posttransplant 54 pertussis vaccination 54 antiandrogen 54 ivabradine 54 postmenopausal hormone therapy 54 cytotoxic chemotherapy 54 N acetylcysteine 54 preoperative chemotherapy 54 levodopa 54 relapsed MM 54 octreotide LAR 54 β blockers 54 adjuvant therapy 54 latent tuberculosis infection 54 cervical lesions 54 PegIFN RBV 54 biologic therapy 54 pneumococcal vaccination 54 AZOR 54 HCV infection 54 neurologic progression 54 warfarin therapy 54 testosterone supplementation 54 tocilizumab 54 CD4 count 54 BYSTOLIC 54 symptom onset 54 bendamustine 54 leukemia ALL 54 erlotinib 54 Raltegravir 54 candesartan 54 allopurinol 54 hepatitis C genotype 54 coinfection 54 LEXIVA 54 IFN beta 54 regimens 54 imatinib Gleevec 54 solifenacin 54 anti retroviral therapies 54 recurrent venous thromboembolism 54 efavirenz Sustiva 54 saquinavir 54 aldosterone antagonists 54 IV bisphosphonates 54 chronic HCV 54 pimozide 54 dasatinib 54 Antiretrovirals 54 antiviral therapies 54 Vacc 4x 54 radioiodine therapy 54 lopinavir ritonavir 54 zidovudine lamivudine 54 unfractionated heparin 54 genital ulcers 54 heavily pretreated patients 54 tenofovir emtricitabine 54 seropositive patients 54 ziprasidone 54 PCV7 54 pomalidomide 54 mitoxantrone 54 ALLHAT 54 Cohort Study MACS 54 nitazoxanide 54 Ribavirin 54 carvedilol 54 antidepressant medication 54 vitamin D supplementation 54 androgen deprivation therapy 54 valacyclovir 54 virological suppression 54 BARACLUDE 54 thrombolytic therapy 54 chemotherapy regimen 54 virologic responses 54 FUZEON 54 receiving VICTRELIS 54 virological 54 inhaled budesonide 54 methotrexate 54 serum creatinine levels 54 hepatitis C infection 54 recurrent VTE 54 CsA 54 tiotropium 54 anti TNFs 54 fluconazole 54 Soliris therapy 54 lupus nephritis 54 glucocorticoids 54 aspirin therapy 54 dosage regimens 54 interferon therapy 54 clodronate 54 adenoma recurrence 54 tenofovir DF 54 CD4 + cell 54 atazanavir ritonavir 54 HBeAg positive 54 LHRH agonists 54 heavily pretreated 53 3TC lamivudine Epivir 53 menopausal hormone therapy 53 antibody titer 53 NPH insulin 53 anticonvulsants 53 adjuvant chemotherapy 53 SSRI 53 FOLFOX4 53 Adjuvant chemotherapy 53 eplerenone 53 experienced virologic failure 53 HIV seronegative 53 zidovudine 53 Pegylated Interferon 53 adjuvant tamoxifen 53 T2DM 53 Combination therapy 53 bortezomib 53 nevirapine NVP 53 Doxil ® 53 mycophenolate mofetil MMF 53 neutrophil counts 53 VZV 53 Trastuzumab 53 VIRAMUNE 53 HBeAg seroconversion 53 RRMS patients 53 Pneumocystis carinii pneumonia 53 pioglitazone 53 NATRECOR R 53 oral ibandronate 53 Interferon 53 log# reduction 53 eculizumab therapy 53 DMARDs 53 lopinavir ritonavir Kaletra 53 posaconazole 53 integrase inhibitor 53 sipuleucel T 53 copies ml 53 CANCIDAS 53 AZT 3TC 53 poliovirus vaccine 53 CR nPR 53 antibiotic prophylaxis 53 Corticosteroids 53 renal function 53 TNF inhibitors 53 Gag polymorphisms 53 mRCC 53 daclizumab 53 tuberculin skin testing 53 vandetanib 53 CD4 + 53 minocycline 53 lymph node dissection 53 velafermin 53 bisphosphonate 53 efavirenz EFV 53 nortriptyline 53 lipid lowering medications 53 rindopepimut 53 Virologic 53 5-FU/LV 53 antifungal therapy 53 nevirapine 53 docetaxel chemotherapy 53 valproate 53 Epivir 53 atypical antipsychotic medications 53 TMC# [001] 53 Peg IFN 53 palivizumab 53 LMWH 53 rapamycin 53 letrozole 53 neutralizing antibodies 53 REYATAZ ® 53 recurrent glioblastoma multiforme 53 oxcarbazepine 53 SIV infected 53 daunorubicin 53 oral anticoagulants 53 abatacept 53 H. pylori eradication 53 3TC 53 Darunavir 53 reinfarction 53 receiving antiretroviral therapy 53 ceftriaxone 53 asymptomatic carotid stenosis 53 estrogen progestin therapy 53 visilizumab 53 BRAF mutation 53 warfarin 53 fulvestrant 53 SCIg 53 LTBI 53 colorectal liver metastases 53 ganciclovir 53 CD4 + cells 53 cabazitaxel 53 Rifampin 53 antihypertensive medication 53 Prophylaxis 53 EXJADE 53 chemotherapy docetaxel 53 Decitabine 53 genital herpes infections 53 anti leukemic 53 comparator PI r 53 MULTAQ 53 aldosterone antagonist 53 HIV 53 nucleoside reverse transcriptase inhibitors 53 lapatinib Tykerb 53 steroid dexamethasone 53 teriparatide 53 APTIVUS ritonavir 53 artesunate 53 ATACAND 53 clopidogrel 53 Infected Patients 53 revaccination 53 pegfilgrastim 53 maraviroc 53 olmesartan 53 chemoprophylaxis 53 abacavir Ziagen 53 vancomycin 53 pegylated interferon alpha 53 COPD exacerbations 53 NAbs 53 chlorambucil 53 HbA1c levels 53 spontaneous preterm birth 53 cidofovir 53 NRTI backbone 52 relapsed ovarian cancer 52 thyroxine 52 ACE inhibitor 52 tolvaptan 52 disease modifying antirheumatic 52 complete cytogenetic response 52 placebo dexamethasone 52 peginterferon alfa 52 adalimumab Humira 52 Nevirapine 52 calcitriol 52 anakinra 52 artemisinins 52 immunosuppressive medications 52 AGILECT R 52 citalopram 52 nucleoside analog 52 placebo 52 quetiapine 52 severe oral mucositis 52 loop diuretics 52 pegylated liposomal doxorubicin 52 Highly Active 52 TORISEL 52 dexamethasone 52 antithrombotic 52 retroviral therapy 52 bevacizumab 52 dosing regimens 52 viral kinetics 52 hormonal therapies 52 preterm deliveries 52 liver histology 52 canakinumab 52 hormonal contraception 52 T1DM 52 metastatic renal cell carcinoma 52 aromatase inhibitor therapy 52 Revlimid lenalidomide 52 cyclosporine 52 zinc supplementation 52 Dasatinib 52 serum calcium 52 ACTIVE W 52 biochemical recurrence 52 low dose ritonavir 52 subclinical hypothyroidism 52 montelukast 52 inhaled corticosteroids 52 Torisel 52 HbF 52 undetectable HBV DNA 52 gemifloxacin 52 dapsone 52 neutralizing antibody 52 HPTN 52 interferon IFN 52 bezafibrate 52 post exposure prophylaxis 52 SSRI antidepressant 52 antithrombotic therapy 52 neoadjuvant therapy 52 lenalidomide Revlimid R 52 antipsychotic medications 52 adjuvant radiotherapy 52 cinacalcet 52 tenofovir FTC 52 neuroleptics 52 transgene expression 52 HER2 positive breast cancer 52 gliclazide 52 FASLODEX 52 aripiprazole 52 metastatic lung cancer 52 splenectomized patients 52 KRAS mutant tumors 52 fondaparinux 52 mg kg dose 52 certolizumab pegol 52 dose regimen 52 IGFBP 52 oral bisphosphonates 52 estrogen therapy 52 dexamethasone Decadron 52 Anti retroviral therapy 52 cranial irradiation 52 varicella vaccine 52 hormone therapy 52 corticosteroid 52 Multicenter AIDS 52 BEACOPP 52 typical antipsychotics 52 VFEND 52 acid suppressive medications 52 ACE inhibitors 52 TNFa 52 amodiaquine 52 amisulpride 52 paclitaxel Taxol 52 prednisone prednisolone 52 endometrial carcinoma 52 serum testosterone 52 ritonavir 52 DFMO 52 telomerase activation 52 rHuPH# 52 SHPT 52 immunosuppressive drugs 52 immunomodulatory therapies 52 chlamydial infection 52 Anti TNF 52 TACE 52 antiepileptic drug 52 lung metastasis 52 antiretroviral ARV treatment 52 MMP inhibitors 52 sertraline 52 bladder carcinoma 52 inotropic 52 NSTE ACS 52 PREZISTA ritonavir 52 alfa 2a 52 liver transplant recipients 52 thiazide diuretics 52 dexrazoxane 52 REYATAZ R 52 fluvastatin 52 REYATAZ ritonavir 52 peg IFN 52 sotalol 52 HBeAg positive patients 52 pegylated interferon alfa 52 EPZICOM 52 tPA 52 serum HCV RNA 52 neostigmine 52 antidiabetic therapy 52 anticoagulation 52 imatinib resistance 52 bevacizumab Avastin 52 CCR5 tropic HIV 52 gefitinib 52 sildenafil Viagra 52 serum lipid levels 52 elvitegravir 52 seropositivity 52 nucleoside 52 OADs 52 IFN alfa 52 basal insulin 52 adrenal suppression 52 Antiretroviral 52 temozolomide 52 systemic corticosteroids 52 recurrent GBM 52 detectable HCV RNA 52 concomitant medications 52 rifabutin 52 DMARD therapy 52 polytherapy 52 antituberculosis 52 Celecoxib 52 KOMBIGLYZE XR 52 HBsAg 52 Velcade bortezomib 52 TMC# r 52 K#N 52 panobinostat 52 sorafenib 52 allogeneic SCT 52 triple nucleoside 52 DMPA 52 Fludara 51 temsirolimus 51 folic acid supplementation 51 Bevacizumab 51 standard chemotherapy regimens 51 nonnucleoside reverse transcriptase inhibitors 51 cetuximab 51 urate levels 51 postoperative AF 51 androgen suppression 51 nephrotoxicity 51 dutasteride 51 HBV vaccine 51 standard chemotherapy regimen 51 pharmacotherapy 51 SHBG levels 51 lymphocyte count 51 dose cytarabine 51 anagrelide 51 pegIFN 51 efalizumab 51 adiponectin levels 51 prostate cancer CaP 51 serum phosphate 51 CD4 T 51 rFSH 51 antipsychotics 51 CHOP chemotherapy 51 randomized trials 51 mcg dose 51 GIST tumors 51 Hepsera 51 anticoagulant therapy 51 fluorouracil 51 amprenavir 51 fibrinolytic 51 dose cyclophosphamide 51 fluoxetine 51 insulin degludec 51 irinotecan 51 rifampin 51 Dose escalation 51 Liver transplantation 51 Pegasys plus Copegus 51 achieved sustained virological 51 copies mL 51 PREZISTA rtv 51 tricyclic antidepressant 51 serum clusterin levels 51 idraparinux 51 Hb A1C 51 Pemetrexed 51 prednisone 51 VIDAZA 51 neutropenic patients 51 Kivexa 51 PCa 51 Hb levels 51 herpes zoster vaccine 51 oral anticoagulation 51 relapsers 51 HBeAg 51 omalizumab 51 serum testosterone levels 51 antibody responses 51 interferon alpha 51 pCR 51 alpha 2a 51 atazanavir sulfate 51 sitagliptin 51 nutlin 3a 51 angiotensin receptor blockers 51 antiangiogenic 51 EBV infection 51 lenalidomide dexamethasone 51 Traficet EN 51 uric acid lowering 51 serum calcium levels 51 CCR5 antagonist 51 hemoglobin A1c levels 51 subgroup analyzes 51 adrenal function 51 UDCA 51 calcium supplementation 51 riociguat 51 epoetin beta 51 genotypic 51 immunocompetent 51 antiretroviral treatments 51 oral naltrexone 51 caspofungin 51 genital ulcer disease 51 immunomodulatory therapy 51 KRAS status 51 imetelstat 51 antiepileptic drugs AEDs 51 Reverset 51 tricyclic antidepressants 51 suboptimal adherence 51 5 FU 51 Myelodysplastic Syndrome MDS 51 rifapentine 51 NRTI resistance 51 Cisplatin 51 dosing schedules 51 fluoxetine Prozac 51 abacavir containing 51 anti retroviral drugs 51 voriconazole 51 linezolid 51 OHR/AVR# 51 serum sodium 51 sinus rhythm 51 aprepitant 51 sulfasalazine 51 leukotriene receptor antagonist 51 buprenorphine naloxone 51 ethambutol 51 lymphocyte counts 51 administered subcutaneously 51 glargine 51 pemetrexed 51 pimecrolimus 51 anthracycline 51 GHRH 51 cytotoxic therapy 51 CCyR 51 CD4 + T 51 antidiabetic medication 51 saquinavir ritonavir 51 FOLFIRI 51 Viral load 51 Isoniazid 51 seropositive 51 buprenorphine 51 intensive statin therapy 51 ALT flares 51 subtrochanteric 51 Monotherapy 51 chronic hepatitis 51 Peginterferon 51 antiandrogens 51 interferon beta therapy 51 anthracycline containing 51 maximal doses 51 Viread Emtriva 51 aromatase inhibitor 51 placental malaria 51 antiangiogenic therapy 51 severe rotavirus gastroenteritis 51 ABC/3TC 51 chemotherapeutic regimens 51 glitazones 51 BCG vaccine 51 glucose lowering 51 epirubicin 51 HCV genotype 1 51 Influenza vaccination 51 desvenlafaxine succinate 51 CD4 cells 51 epoetin 51 SELZENTRY 51 VICTRELIS 51 EGFR inhibitors 51 neuroleptic 51 antiplatelet drugs 51 eGFR 51 telomere lengths 51 candidemia 51 Thal Dex 51 tacrolimus 51 latent TB infection 51 Naive Patients 51 flutamide 51 indapamide 51 rosiglitazone 51 BEXXAR Therapeutic Regimen 51 biologic DMARD 51 Retreatment 51 Telintra 51 SLNB 51 relapsing MS 51 multivitamin supplements 51 MGUS 51 thrombolytics 51 tamsulosin 51 Gleevec imatinib 51 conjugated equine estrogen 51 stage IIIB 51 Subgroup analyzes 51 elevated CRP 51 gemcitabine 51 antibiotic regimens 51 CAMMS# 51 taxane therapy 51 iron supplementation 51 advanced neoplasia 51 hydroxyvitamin D levels 51 H pylori 51 transaminase elevations 51 nucleotide analog 51 Femara 51 FTC TDF 51 prophylactic treatment 51 chronic GVHD 51 rt PA 51 imipramine 51 lamivudine refractory patients 51 anticoagulation therapy 51 plus ribavirin 51 serum estradiol 51 azithromycin 51 PROLASTIN 51 amoxicillin clavulanate 51 haloperidol Haldol 51 Mylotarg 51 immune reconstitution 51 PTLD 51 LHRH agonist 51 romiplostim 51 CellCept 51 epoetin alfa 51 thromboembolic disease 51 refractory HL 51 NATRECOR ® 51 CYP#D# 51 ORENCIA 51 COMBIVIR 51 thromboprophylaxis 51 IDUs 51 retransplantation 51 LY# [003] 51 CCR5 tropic 51 immunosuppressant drugs 51 Jevtana 51 prostate cancer CRPC 51 interferon alfa 51 asymptomatic 51 Etanercept 51 overt hypothyroidism 51 avosentan 51 herpes zoster shingles 51 cefuroxime 51 uridine triacetate 51 lapatinib 51 antibody titers 51 imipenem 51 risedronate 51 BCG vaccination 51 serum vitamin D 50 biochemical relapse 50 levodopa therapy 50 somatostatin analogs 50 paroxetine 50 randomized clinical 50 cyclophosphamide 50 superficial bladder cancer 50 Pegasys ® 50 hypogonadal men 50 abiraterone acetate 50 GBV C 50 herpes infection 50 EDSS scores 50 hematologic toxicity 50 fluoroquinolone resistance 50 Nilotinib 50 isoflavone supplement 50 ancrod 50 HIV coinfected 50 bisphosphonates 50 EDARBI 50 serum uric acid 50 refractory AML 50 relapsed 50 Tipranavir 50 PROLASTIN C 50 rFIXFc 50 amphotericin B 50 chronic hepatitis C 50 timepoint 50 renal allograft 50 mucosal healing 50 metreleptin 50 Lenalidomide 50 oxyntomodulin 50 neoadjuvant treatment 50 PREZISTA 50 PAOD 50 EGFRIs 50 dose escalation 50 Herceptin trastuzumab 50 vaginal progesterone 50 poor metabolizers 50 chlorthalidone 50 losartan 50 EGFR TKI 50 acyclovir 50 pramlintide 50 androgen deficiency 50 Blinatumomab 50 PPSV# 50 dose Nevirapine 50 INFERGEN 50 pregabalin 50 NUCYNTA R 50 transgenic rats 50 weekly subcutaneous injections 50 leflunomide 50 relapsed AML 50 adriamycin 50 virologic breakthrough 50 vaginal microbicides 50 weekly intravenous infusions 50 thiazide diuretic 50 euthyroid 50 INCB# [001] 50 Follicular Lymphoma 50 plasma folate 50 anti VEGF 50 BENICAR HCT 50 q8h

Back to home page